| Name |
|
Shishir Maithel MD |
| Organization |
|
Emory University, Winship Cancer Institute |
| Can you tell us a bit about yourself? |
|
I am a Professor of Surgery, Scientific Director of the Emory Liver and Pancreas Center, and Director of the Katz Foundation Research Fellowship in Surgical Oncology at Emory University, Winship Cancer Institute. |
| Can you share one or two of your specific research interests? |
|
Along with leading multiple collaborative research efforts across the United States and being the National Principal Investigator of the US Extrahepatic Biliary Malignancy Consortium, I am leading several clinical trials that focus on delivering novel neoadjuvant therapy regimens to patients prior to undergoing resection of their tumors. |
| Why did you decide to specialize in hepatobiliary cancers? |
|
There is so much to learn in treating these cancers. The research possibilities and opportunities for clinical trials was very attractive to me. Furthermore, as a Surgical Oncologist, I found the anatomy, physiology, and technical challenges in the operating room very appealing. |
| Can you describe one of the unforgettable moments in your patients care or research that has impacted your career? |
|
I continually learn from and am inspired by the strength of my patients on a daily basis. Patients are placed in positions where they must endure so much more that I have ever experienced in my own life. Their demonstration of the resilience of the human spirit is truly inspiring on a daily basis. |
| Can you tell us one thing collaboration with colleagues could accomplish that you could not accomplish on your own? |
|
Conducting clinical trials and quality research is all about cooperating and collaborating with colleagues. I could not have accomplished any of my research without the support, mentorship, and friendship from my colleagues around the country and world. |
| If you had access to one resource that would move your research forward, what would that resource be? |
|
An endless pot of money. |
| How did you learn about the Cholangiocarcinoma Foundation? |
|
I was introduced to the CCF by my colleague Dr. Flavio Rocha in 2015. |
| Can you tell us why you became a member of the ICRN? |
|
The ICRN provided a strong and rich environment to develop research ideas and a vast network in which to conduct clinical trials. |
| If you are one of our Cholangiocarcinoma Foundation Fellowship awardees, how has this Fellowship impacted your career? |
|
N/A |
